You are here

  • Home
  • Archive
  • Volume 21, Issue 5
  • After precessation nicotine replacement therapy, abrupt cessation increases abstinence more than gradual cessation in smokers ready to quit

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
After precessation nicotine replacement therapy, abrupt cessation increases abstinence more than gradual cessation in smokers ready to quit
  1. Elias M Klemperer,
  2. John R Hughes
  1. University of Vermont, Burlington, Vermont, USA
  1. Correspondence to: Elias M Klemperer, University of Vermont, UHC Campus, Mailstop 482 OH4, 1 S. Prospect St., Burlington, VT 05401, USA; elias.klemperer{at}med.uvm.edu

https://doi.org/10.1136/ebmed-2016-110489

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Lindson-Hawley N, Banting M, West R, et al. Gradual versus abrupt smoking cessation a randomized, controlled noninferiority trial gradual versus abrupt smoking cessation. Ann Intern Med 2016;164:585–92OpenUrlCrossRefPubMed.

    Context

    Most guidelines recommend abrupt smoking cessation; however, gradual cessation is common. Reducing cigarettes per day (CPD) with nicotine replacement therapy (NRT) increases cessation among smokers who are not ready to quit.1 However, whether gradual reduction is effective for smokers who want to quit now is unclear.2

    Methods

    This randomised controlled trial compared gradual cessation (ie, reduction in CPD) with abrupt cessation among smokers ready to quit (N=697). The gradual-cessation group received 2 weeks of NRT patches, short-acting …

    View Full Text

    Footnotes

    • Funding NIDA T32 DA07242.

    • Competing interests EMK has nothing to disclose. JRH has received consulting and speaking fees from several companies that develop or market pharmacological and behavioural treatments for smoking cessation or harm reduction and from several non-profit organisations that promote tobacco control. He also consults (without payment) for Swedish match.

    • Provenance and peer review Commissioned; internally peer reviewed.